These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 21040087)

  • 41. Treating osteoporosis: do bisphosphonates really increase the risk of osteonecrosis of the jaw?
    Thompson E; Sheehy C; Barry M; Carey J
    Ir Med J; 2008 Jun; 101(6):166-7. PubMed ID: 18700507
    [No Abstract]   [Full Text] [Related]  

  • 42. Bisphosphonate-related osteonecrosis of the jaw: the role of actinomyces.
    Naik NH; Russo TA
    Clin Infect Dis; 2009 Dec; 49(11):1729-32. PubMed ID: 19886792
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Bisphosphonates and jaw osteonecrosis: the UAMS experience.
    Clarke BM; Boyette J; Vural E; Suen JY; Anaissie EJ; Stack BC
    Otolaryngol Head Neck Surg; 2007 Mar; 136(3):396-400. PubMed ID: 17321866
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comprehensive review of bisphosphonate therapy: implications for the oral and maxillofacial surgery patient.
    Ruggiero SL; Carlson ER; Assael LA
    J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):1. PubMed ID: 19371808
    [No Abstract]   [Full Text] [Related]  

  • 45. Advantages and disadvantages of the use of bisphosphonates in oral and maxillofacial surgery.
    de Souza Loureiro CC; Leandro LF
    Int Dent J; 2010 Aug; 60(4):263-8. PubMed ID: 20949756
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Bisphosphonates and osteonecrosis of the jaw].
    Saussez S; Filleul O; Loeb I
    Rev Stomatol Chir Maxillofac; 2008 Dec; 109(6):367-73. PubMed ID: 19013624
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Association between osteonecrosis of the jaws and chronic high-dosage intravenous bisphosphonates therapy.
    Graziani F; Cei S; La Ferla F; Cerri E; Itro A; Gabriele M
    J Craniofac Surg; 2006 Sep; 17(5):876-9. PubMed ID: 17003614
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Diphosphonate therapy and osteonecrosis of the jaw].
    Løkken P; Skoglund LA; Skjelbred P
    Tidsskr Nor Laegeforen; 2007 Aug; 127(15):1945-7. PubMed ID: 17700737
    [No Abstract]   [Full Text] [Related]  

  • 49. Bisphosphonates, hypercalcemia of malignancy, and osteonecrosis of the jaw.
    Wynn RL
    Gen Dent; 2005; 53(6):392-5. PubMed ID: 16366043
    [No Abstract]   [Full Text] [Related]  

  • 50. Bisphosphonate-related osteonecrosis of the jaws: a review of 34 cases and evaluation of risk.
    Kyrgidis A; Vahtsevanos K
    J Craniomaxillofac Surg; 2011 Jun; 39(4):271. PubMed ID: 20434920
    [No Abstract]   [Full Text] [Related]  

  • 51. Oral bisphosphonate therapy and osteonecrosis of the jaw: what to tell the concerned patient.
    Koka S; Clarke BL; Amin S; Gertz M; Ruggiero SL
    Int J Prosthodont; 2007; 20(2):115-22. PubMed ID: 17455429
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Oral bisphosphonate-induced osteonecrosis: risk factors, prediction of risk using serum CTX testing, prevention, and treatment.
    ; Khosla S; Burr D; Cauley J; Dempster DW; Ebeling PR; Felsenberg D; Gagel RF; Gilsanz V; Guise T; Koka S; McCauley LK; McGowan J; McKee MD; Mohla S; Pendrys DG; Raisz LG; Ruggiero SL; Shafer DM; Shum L; Silverman SL; Van Poznak CH; Watts N; Woo SB; Shane E
    J Oral Maxillofac Surg; 2008 Jun; 66(6):1320-1; author reply 1321-2. PubMed ID: 18486811
    [No Abstract]   [Full Text] [Related]  

  • 53. Tooth extraction: Is it inciting event or sequela of osteonecrosis of the jaws associated with intravenous bisphosphonates?
    Altundag K; Bulut N; Tezcan E; Ozen M; Purnak T
    J Oral Maxillofac Surg; 2007 Jan; 65(1):154. PubMed ID: 17174785
    [No Abstract]   [Full Text] [Related]  

  • 54. Osteonecrosis of the jaw in patients receiving intravenous or oral bisphosphonates.
    King AE; Umland EM
    Pharmacotherapy; 2008 May; 28(5):667-77. PubMed ID: 18447663
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Bisphosphonates and osteonecrosis of the jaws: science and rationale.
    Gutta R; Louis PJ
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Aug; 104(2):186-93. PubMed ID: 17448709
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Resolution of oral bisphosphonate and steroid-related osteonecrosis of the jaw--a serial case analysis.
    Chiu CT; Chiang WF; Chuang CY; Chang SW
    J Oral Maxillofac Surg; 2010 May; 68(5):1055-63. PubMed ID: 20403529
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Bisphosphonate-related osteonecrosis: genetic and acquired risk factors.
    Sarasquete ME; González M; San Miguel JF; García-Sanz R
    Oral Dis; 2009 Sep; 15(6):382-7. PubMed ID: 19413677
    [TBL] [Abstract][Full Text] [Related]  

  • 58. An experimental study of bisphosphonate-induced jaws osteonecrosis in Sprague-Dawley rats.
    López-Jornet P; Camacho-Alonso F; Molina-Miñano F; Gómez-García F; Vicente-Ortega V
    J Oral Pathol Med; 2010 Oct; 39(9):697-702. PubMed ID: 20819131
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Bisphosphonate treatment as a cause of jaw osteonecrosis.
    Kanat O; Ozet A; Ataergin S; Kuzhan O; Arpaci F; Ozturk B; Komurcu S; Ozturk M
    Oral Dis; 2007 May; 13(3):346-7. PubMed ID: 17448221
    [No Abstract]   [Full Text] [Related]  

  • 60. American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws.
    Advisory Task Force on Bisphosphonate-Related Ostenonecrosis of the Jaws, American Association of Oral and Maxillofacial Surgeons
    J Oral Maxillofac Surg; 2007 Mar; 65(3):369-76. PubMed ID: 17307580
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.